Topical gel for preventing stretch marks now available; New market forecast published;

> Switzerland's Stratpharma AG has developed topical gel for the prevention and treatment of stretch marks, which occur during pregnancy. The CE marked medical device is available for sale in Europe. Release

> Drug Delivery Technologies has released a market forecast for 2014 to 2024. It includes the prospects of various administration routes, including nasal, ocular and transdemeral. Also included are the prospects of various biologics such as monoclonal antibodies and insulins. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.